SCHEMBL9467353

SCHEMBL9467353

Cc1ccc(S(=O)(=O)OCC2(Cc3ccccc3)CCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
CA12 O43570 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
ATM Q13315 1/20 0.41
CA9 Q16790 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
MCHR1 Q99705 1/20 0.40
NR3C1 P04150 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KMT2A Q03164 1/20 0.39
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
LMNA P02545 1/20 0.38
VDR P11473 1/20 0.38
CNR2 P34972 2/20 0.37
AR P10275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11637311 0.85 KMT2A (0.47) CA12CYP1A2CYP3A4CA9ALDH1A1
SCHEMBL16835 0.81 KMT2A (0.44) CA12CYP1A2CYP3A4CA9ALDH1A1
SCHEMBL7849587 0.81 KMT2A (0.50) CA12CYP3A4CA9ALDH1A1GAA
SCHEMBL30140023 0.80 KMT2A (0.42) CYP3A4ALDH1A1GAASMN1; SMN2KMT2A
SCHEMBL18047923 0.79 SMN1; SMN2 (0.46) CA12CYP1A2CYP3A4CA9ALDH1A1
SCHEMBL18334492 0.79 KMT2A (0.41) CYP3A4ALDH1A1GAASMN1; SMN2KMT2A
SCHEMBL18218 0.79 KMT2A (0.47) CA12CYP3A4CA9ALDH1A1GAA
SCHEMBL30200580 0.78 ALDH1A1 (0.43) ATMALDH1A1GAASMN1; SMN2KMT2A
SCHEMBL17442 0.77 KMT2A (0.46) CA12CYP3A4CA9ALDH1A1GAA
SCHEMBL29906344 0.77 SMN1; SMN2 (0.42) CA12CYP1A2CYP3A4CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5194437-A Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders ADIR ET COMPAGNIE (FR) 1993-03-16 US disclosed
US-5173490-A Antipsychotic drugs having no side effects; anxiolytic agents; analgesics; tranquilizers; sedatives; antidepressants ADIR ET COMPAGNIE (FR) 1992-12-22 US disclosed